您的位置:网站名称 → 研发专利新闻 → 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

USPTO issues notice of allowance to Mirna's mir34a patent application


Mirna Therapeutics, Inc. ( Mirna ) announced today that the United States Patent and Trademark Office has allowed patent claims related to the therapeutic application of the potent tumor suppressor microRNA, mir34a. The currently allowed...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

• Shire files lawsuit against Watson over
• Cubist enters license agreement with Tev
• Medical industry veteran set to play key
• USPTO issues patent to Asterand's BioMAP
• USPTO grants composition-of-matter paten
• USPTO issues patent to Somaxon's Silenor
• USPTO issues Notice of Allowance to Modu
• Biotectix acquires Chameleon BioSurfaces
• U.S. District Court rules in favor of Wa
• US District Court rules against Watson i
• EPO Board of Appeal rejects B.Braun pate
• Watson confirms patent challenge by Alco
• USPTO issues new patent to Onset Medical
• Echo awarded method patent for Symphony
• EPO grants patent to OncoGenex OGX-427 f
• QRxPharma receives new U.S. Patent for M
• U.S. District Court grants preliminary i
• Acorda receives patent for AMPYRA tablet
• Salix Pharmaceuticals receives three U.S
• Watson Laboratories seeks FDA approval t

相关评论


本文章所属分类:首页 → 研发专利新闻